Zacks: Analysts Expect MAXIMUS, Inc. (MMS) Will Post Earnings of $0.77 Per Share
Equities analysts predict that MAXIMUS, Inc. (NYSE:MMS) will announce earnings of $0.77 per share for the current quarter, according to Zacks Investment Research. Five analysts have issued estimates for MAXIMUS’s earnings. The lowest EPS estimate is $0.75 and the highest is $0.79. MAXIMUS reported earnings per share of $0.71 in the same quarter last year, which suggests a positive year-over-year growth rate of 8.5%. The company is expected to report its next quarterly earnings report on Thursday, February 8th.
On average, analysts expect that MAXIMUS will report full-year earnings of $3.05 per share for the current fiscal year, with EPS estimates ranging from $3.00 to $3.11. For the next year, analysts expect that the company will report earnings of $3.33 per share, with EPS estimates ranging from $3.28 to $3.40. Zacks Investment Research’s EPS calculations are an average based on a survey of research analysts that cover MAXIMUS.
Several equities analysts have recently issued reports on the company. Zacks Investment Research raised MAXIMUS from a “hold” rating to a “buy” rating and set a $73.00 target price on the stock in a research note on Wednesday, October 4th. Canaccord Genuity reissued a “buy” rating on shares of MAXIMUS in a research note on Wednesday, December 27th. Two investment analysts have rated the stock with a sell rating, five have assigned a hold rating and one has given a buy rating to the stock. The company presently has a consensus rating of “Hold” and a consensus price target of $64.33.
Hedge funds and other institutional investors have recently added to or reduced their stakes in the stock. Acrospire Investment Management LLC boosted its holdings in MAXIMUS by 17.6% in the second quarter. Acrospire Investment Management LLC now owns 2,000 shares of the health services provider’s stock worth $125,000 after acquiring an additional 300 shares in the last quarter. Zurcher Kantonalbank Zurich Cantonalbank boosted its holdings in MAXIMUS by 10.2% in the second quarter. Zurcher Kantonalbank Zurich Cantonalbank now owns 2,367 shares of the health services provider’s stock worth $148,000 after acquiring an additional 220 shares in the last quarter. Intl Fcstone Inc. bought a new stake in MAXIMUS in the second quarter worth $201,000. OLD National Bancorp IN bought a new stake in MAXIMUS in the third quarter worth $246,000. Finally, Cubist Systematic Strategies LLC boosted its holdings in MAXIMUS by 16.0% in the second quarter. Cubist Systematic Strategies LLC now owns 3,969 shares of the health services provider’s stock worth $249,000 after acquiring an additional 546 shares in the last quarter. Institutional investors own 94.79% of the company’s stock.
MAXIMUS (NYSE:MMS) traded down $0.22 on Wednesday, hitting $71.36. The stock had a trading volume of 335,200 shares, compared to its average volume of 284,000. MAXIMUS has a 52-week low of $51.74 and a 52-week high of $72.54. The stock has a market capitalization of $4,662.48, a PE ratio of 22.44, a PEG ratio of 2.69 and a beta of 1.34.
WARNING: This story was published by American Banking News and is owned by of American Banking News. If you are reading this story on another publication, it was stolen and republished in violation of US and international copyright & trademark legislation. The correct version of this story can be read at https://www.americanbankingnews.com/2018/01/03/zacks-analysts-expect-maximus-inc-mms-will-post-earnings-of-0-77-per-share.html.
MAXIMUS, Inc provides business process services (BPS) to government health and human services agencies. The Company operates through three segments: U.S. Federal Services, Health Services and Human Services. The U.S. Federal Services segment provides BPS and program management for large government programs, independent health review and appeals services for both the United States Federal Government, and state-based programs and technology solutions for civilian federal programs.
For more information about research offerings from Zacks Investment Research, visit Zacks.com
Receive News & Ratings for MAXIMUS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for MAXIMUS and related companies with MarketBeat.com's FREE daily email newsletter.